NCT01153698 - Pradaxa (Dabigatran Etexilate) VTE Prevention After Elective Total Hip or Knee Replacement Surgery | Biotech Hunter

Enrollment

167

Participants

Timeline

Start Date

August 31, 2010

Primary Completion Date

December 21, 2011

Study Completion Date

December 21, 2011

Conditions

Venous ThromboembolismArthroplasty, Replacement

Interventions

DRUG

dabigatran

anticoagulation

Trial Locations (7)

1160.118.43004 Boehringer Ingelheim Investigational Site, Braunau am Inn

1160.118.43002 Boehringer Ingelheim Investigational Site, Ehebichl

1160.118.43005 Boehringer Ingelheim Investigational Site, Graz

1160.118.43016 Boehringer Ingelheim Investigational Site, Stolzalpe

1160.118.43001 Boehringer Ingelheim Investigational Site, Vienna

1160.118.43007 Boehringer Ingelheim Investigational Site, Vienna

1160.118.43011 Boehringer Ingelheim Investigational Site, Vienna